294 related articles for article (PubMed ID: 27771353)
1. G-CSF treatment promotes apoptosis of autoreactive T cells to restrict the inflammatory cascade and accelerate recovery in experimental allergic encephalomyelitis.
Peng W
Exp Neurol; 2017 Mar; 289():73-84. PubMed ID: 27771353
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of G-CSF administration in microglia-mediated reactive T cell activation in vitro.
Peng W
Immunol Res; 2017 Aug; 65(4):888-902. PubMed ID: 28646409
[TBL] [Abstract][Full Text] [Related]
3. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
[TBL] [Abstract][Full Text] [Related]
4. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
5. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Xu J; Wagoner G; Douglas JC; Drew PD
J Neuroimmunol; 2013 Jan; 254(1-2):46-54. PubMed ID: 23010281
[TBL] [Abstract][Full Text] [Related]
6. Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Benedek G; Zhang J; Bodhankar S; Nguyen H; Kent G; Jordan K; Manning D; Vandenbark AA; Offner H
J Neuroimmunol; 2016 Apr; 293():45-53. PubMed ID: 27049561
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68-86 in Lewis rats: a role for dendritic cells in inducing apoptosis of CD4+ T cells.
Xiao BG; Huang YM; Xu LY; Ishikawa M; Link H
J Neuroimmunol; 1999 Jun; 97(1-2):25-36. PubMed ID: 10408975
[TBL] [Abstract][Full Text] [Related]
8. Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
Frezel N; Sohet F; Daneman R; Basbaum AI; Braz JM
Exp Neurol; 2016 Sep; 283(Pt A):224-34. PubMed ID: 27343802
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
[TBL] [Abstract][Full Text] [Related]
10. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y
J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
[TBL] [Abstract][Full Text] [Related]
12. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Wang D; Li SP; Fu JS; Bai L; Guo L
Int J Dev Neurosci; 2016 Apr; 49():60-6. PubMed ID: 26827767
[TBL] [Abstract][Full Text] [Related]
14. Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
Yin JX; Tang Z; Gan Y; Li L; Shi F; Coons S; Shi J
Neuropharmacology; 2014 Jun; 81():1-5. PubMed ID: 24486709
[TBL] [Abstract][Full Text] [Related]
15. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
16. Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
Borjini N; Fernández M; Giardino L; Calzà L
J Neuroinflammation; 2016 Nov; 13(1):291. PubMed ID: 27846891
[TBL] [Abstract][Full Text] [Related]
17. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation.
Zavala F; Abad S; Ezine S; Taupin V; Masson A; Bach JF
J Immunol; 2002 Feb; 168(4):2011-9. PubMed ID: 11823538
[TBL] [Abstract][Full Text] [Related]
18. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
20. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
Front Immunol; 2018; 9():15. PubMed ID: 29403497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]